Breast cancer drug Herceptin approved for use

Following British Columbia's lead, Ontario, Saskatchewan and Quebec yesterday approved the expensive breast cancer drug Herceptin, which is being considered a breakthrough breast cancer treatment by many doctors.

Ontario approved $148 million over three years to fund three promising cancer treatments, including Herceptin, described by doctors as a breakthrough breast cancer treatment because studies suggest it could prevent the recurrence of breast cancer by up to 50 per cent.

More details on this new wonder drug for breast cancer are available here.